GlassScriptPhysician profile
Joseph Wilson
NPI 1467972497
$16,598.81
in general payments reported to CMS, 2019-2025
35 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.72 · 2020: $3,031 · 2021: $1,878 · 2022: $5,185 · 2023: $1,463 · 2024: $3,919 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,479 · Travel and Lodging: $1,999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,479.43 |
| Travel and Lodging | $1,999.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,061.94 | 2020-2025 | Prostep Mica, Prostep, Augment Injectable |
| Great Lakes Orthopedics | $1,256.73 | 2022 | |
| Smith+Nephew, INC. | $969.75 | 2020-2024 | Collagenase Santyl, Pico, Pico 7 |
| Crossroads Orthopedics, LLC | $874.95 | 2024 | |
| Kerecis Limited | $744.58 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbott Laboratories | $564.91 | 2022-2025 | Proclaim |
| Medela LLC | $328.60 | 2020-2023 | Invia Motion Endure |
| Mimedx Group, INC. | $292.26 | 2025 | |
| Medtronic, INC. | $273.92 | 2021-2023 | Venaseal |
| Melinta Therapeutics, LLC | $218.68 | 2021-2023 | Orbactiv, Kimyrsa |
| Organogenesis INC. | $187.51 | 2020-2025 | Puraply Wound Matrix, Puraply |
| Depuy Synthes Sales INC. | $186.15 | 2021-2024 | Na, Motoband, N/A |
| Horizon Therapeutics Plc | $182.41 | 2020-2021 | |
| Convatec INC. | $179.61 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $147.68 | 2022-2023 | Xarelto |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $133.09 | 2022-2025 | |
| Orthofix Medical, INC. | $120.00 | 2020-2025 | Physio-Stim |
| Fusion Orthopedics USA, LLC | $113.67 | 2024-2025 | |
| Integra Lifesciences Corporation | $104.99 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $91.88 | 2021-2024 | Restrata Wound Matrix |
| Kci USA, INC. | $81.01 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $75.85 | 2022-2025 | Nuzyra |
| Medartis INC. | $57.90 | 2024 | Aptus |
| Misonix INC | $52.91 | 2020-2021 | |
| Medwest Associates | $48.46 | 2021 | |
| Aroa Biosurgery Incorporated | $38.04 | 2022 | |
| Axogen | $35.77 | 2021 | |
| Paragon 28, INC. | $34.28 | 2024 | Mtp |
| Pacira Pharmaceuticals Incorporated | $26.72 | 2019 | |
| Ethicon US, LLC | $22.89 | 2022 | |
| Fidia Pharma USA INC. | $22.09 | 2023 | Triluron, Hymovis |
| Globus Medical, INC. | $21.49 | 2021 | |
| Heron Therapeutics, INC. | $21.22 | 2023 | Zynrelef |
| Ossdsign USA Incorporated | $15.82 | 2025 | Ossdsign Catalyst |
| Nevro Corp. | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.